Constantine S. Tam, Sarah Kamel. Comment on Lipsky et al.: Incidence and Risk Factors of Bleeding-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib. Haematologica 2016;101(3):e123-e123; https://doi.org/10.3324/haematol.2015.139030.